Brind.
  1. Quanterix acquired Akoya Biosciences in 2025, and the company presented at a conference in Boston.

Akoya Biosciences and Quanterix combine to create a high-margin, high-throughput business, with Masoud Toloue serving as CEO of Quanterix.

1 report, 1 independent Updated Aug 8
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Akoya Biosciences and Quanterix combine to create a high-margin, high-throughput business, with Masoud Toloue serving as CEO of Quanterix.

Who's involved

What this event is mainly about
Akoya Biosciences (United States)Quanterix (United States)

Keep exploring

Part of

Quanterix acquired Akoya Biosciences in 2025, and the company presented at a conference in Boston. All 1 developments

The entities involved

Coverage

Newest first; wire copies grouped
  • Business WireQuanterix Releases Financial Results for the Second Quarter of 2025 BILLERICA, Mass., August 07, 2025--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery th